Dr. Rosenbluth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
J2 Brier Hill Court
East Brunswick, NJ 08816Phone+1 732-390-7750- Is this information wrong?
Education & Training
- Drexel University College of Medicine/Hahnemann University HospitalFellowship, Hematology and Medical Oncology, 2002 - 2005
- Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1999 - 2002
- Rutgers Robert Wood Johnson Medical SchoolClass of 1999
Certifications & Licensure
- NJ State Medical License 2007 - 2025
- GA State Medical License 2005 - 2009
- PA State Medical License 2002 - 2005
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2013
Clinical Trials
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Publications & Presentations
PubMed
- 7 citationsCombination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.Dmitry Zak, Michael Styler, Jonathan Z Rosenbluth, Isadore Brodsky> ;Clinical Advances in Hematology & Oncology. 2005 Apr 1
Hospital Affiliations
- Robert Wood Johnson University Hospital SomersetSomerville, New Jersey
- Robert Wood Johnson University Hospital at HamiltonTrenton, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: